Literature DB >> 30810272

Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections.

Xinxiao Gao1,2, Durga Borkar1, Anthony Obeid1, Jason Hsu1, Allen C Ho1, Sunir J Garg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30810272     DOI： 10.1111/aos.14058

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  4 in total

1.  Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.

Authors:  Andre J Witkin; Paul Hahn; Timothy G Murray; J Fernando Arevalo; Kevin J Blinder; Netan Choudhry; Geoff G Emerson; Roger A Goldberg; Stephen J Kim; Joel Pearlman; Eric W Schneider; Homayoun Tabandeh; Robert W Wong
Journal:  J Vitreoretin Dis       Date:  2020-07-01

Review 2.  Literature review and proposal of best practice for ophthalmologists: monitoring of patients following intravitreal brolucizumab therapy.

Authors:  Dara J Kilmartin
Journal:  Ir J Med Sci       Date:  2022-02-01       Impact factor: 1.568

3.  Case Report: A Case of Cotton-Wool Spots After Intravitreal Injection of Conbercept in an Infant With Incontinentia Pigmenti.

Authors:  Licong Liang; Yiliu Yang; Shaochong Bu; Fang Lu
Journal:  Front Med (Lausanne)       Date:  2021-12-21

4.  Bilateral blindness after uneventful brolucizumab injection for macular degeneration.

Authors:  Ilan Barchichat; Michael Thiel; Oliver Job; Martin Schmid
Journal:  BMC Ophthalmol       Date:  2022-02-16       Impact factor: 2.209
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.